# INOGEN, INC. (INGN) · Edgar & Edgarette company card

> Inogen (INGN) grew revenue 3.9% in FY2025 to $349 million, operating margin -8.7% against a 11.0% median for orthopedic, prosthetic & surgical appliances & supplies, equity 64.4% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1294133 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/INGN) · [JSON](https://www.pops4.com/boards/company/INGN.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $349M |
| Revenue growth, 1 year | 3.9% |
| Revenue growth per year | -0.7% |
| Operating margin | -8.7% (prior year -12.7%) |
| Net margin | -6.5% |
| Operating cash flow | −$11M |
| Capital spending | $3M |
| Free cash flow | −$14M |
| Cash | $104M |
| Long-term debt | — |
| Total assets | $299M |
| Total equity | $192M |
| Equity ÷ assets | 64.4% |
| Return on equity | -11.8% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 2.26 (grey zone)
- Piotroski F: 5 of 9 (middling)
- Beneish M: -2.32 (below the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative; operating loss: a margin of -8.7% in FY2025
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $348.7M (FY2025). Experience: revenue up 3.9% on the year, down 0.7% a year over 4 years; operating margin -8.7%, up from -12.7%. Soundness: equity 64.4% of assets, return on equity -11.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $288.0M and $411.2M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $263.1M to $451.6M. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, orthopedic, prosthetic & surgical appliances & supplies): operating margin -8.7% against a 11.0% median; growth 3.9% against 7.5%.

Range logged 2026-10-01, receipt 7191db1d26fb96c0, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 5, latest 2026-11-05 ([filing](https://www.sec.gov/Archives/edgar/data/1294133/000129413326000040/0001294133-26-000040-index.htm))

## Recent filings

- 10-Q · filed 2026-11-09 · [filing](https://www.sec.gov/Archives/edgar/data/1294133/000129413326000043/0001294133-26-000043-index.htm)
- 8-K · filed 2026-11-05 · 2.01 Completion of Acquisition or Disposition of Assets; 2.02 Results of Operations and Financial Condition; 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1294133/000129413326000040/0001294133-26-000040-index.htm)
- 8-K · filed 2026-09-30 · 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1294133/000129413326000037/0001294133-26-000037-index.htm)
- 10-Q · filed 2026-08-07 · [filing](https://www.sec.gov/Archives/edgar/data/1294133/000129413326000034/0001294133-26-000034-index.htm)
- 8-K · filed 2026-08-06 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1294133/000129413326000032/0001294133-26-000032-index.htm)
- 8-K · filed 2026-07-01 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1294133/000129413326000025/0001294133-26-000025-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001294133.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1294133

## Cite

POPS4, Edgar & Edgarette: INOGEN, INC. (INGN) company card, from the company's own SEC filings, accessed 2026-11-15, https://www.pops4.com/boards/company/INGN. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.